Morphological profile and receptor status in breast carcinoma: an institutional study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cancer Research and Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0973-1482.110358PMID 23575073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic Impact of Triple Negative Phenotype in Conservatively Treated Breast Cancer

  2011cited by this paper
• Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.

  2011cited by this paper
• Molecular classification of breast cancer: is it time to pack up our microscopes?

  2011cited by this paper
• Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India.

  2011cited by this paper
• Breast carcinoma in Uganda: microscopic study and receptor profile of 45 cases.

  2011cited by this paper
• Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.

  2011cited by this paper
• HER2: biology, detection, and clinical implications.

  2011cited by this paper
• ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women.

  2010cited by this paper
• American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

  2010cited by this paper
• Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer

  2010cited by this paper
• Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival

  2009cited by this paper
• Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is?

  2009cited by this paper
• Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

  2008cited by this paper
• Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.

  2008cited by this paper
• Prognostic markers in triple‐negative breast cancer

  2007cited by this paper
• Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

  2007cited by this paper
• Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.

  2005cited by this paper
• Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas.

  2005cited by this paper
• Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer.

  2005cited by this paper
• Hormone receptor status of breast cancer in India: a study of 798 tumours.

  2000cited by this paper
• Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.

  1994cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper

• Histopathological correlation with molecular classification of breast carcinoma in a rural population of Pune Maharashtra, India

  2026cites this paper
• A Study of Correlation of Expression of Er, Pr & Her2neu Receptor Status with the Clinico-pathological Prognostic Factor in Breast Carcinoma

  2025cites this paper
• Novel Insights Into the Epidemiological and Clinico-Pathological Profile of Triple-Negative Breast Cancer: Dissection of an Aggressive Variant

  2024cites this paper
• Prevalence of basal-like phenotype in triple-negative invasive breast carcinomas and a review of the literature

  2024cites this paper
• High prevalance of triple negative markers in breast cancer patients in North Maharashtra

  2023cites this paper
• Yassir Alaa Muhammed Hassan Shubbar CORRELATION BETWEEN DIFFERENT CLINICOPATHOLOGICAL PARAMETERS AND MOLECULAR SUBTYPES OF FEMALE BREAST CARCINOMA IN SOUTH REGION OF IRAQ.

  2023cites this paper
• Study of microvessel density in breast carcinoma with CD34 immunostaining – An institutional experience in Puducherry

  2023cites this paper
• Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer

  2023cites this paper
• Correlation of Expression of Androgen Receptors and P16 in Triple Negative Breast Carcinoma - A Five Years Retrospective and Prospective Study

  2023influential citation
• Prospective Evaluation of Response Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

  2022cites this paper
• Relationship of ER, PR, HER2 / neu with Other Prognostic Factors in Breast Cancer along with the Role of Androgen Receptor in Triple Negative Breast Cancer

  2021cites this paper
• Assessment of Breast Cancer Immunohistochemical Properties with Demographics and Pathological Features; A Retrospective Study

  2021cites this paper
• Immunohistochemical Markers in Breast Cancer: A Cross-Sectional Study on Triple-Negative Breast Cancer in a Rural Tertiary Care Hospital

  2021cites this paper
• Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence

  2021cites this paper
• UTILITY OF PANEL OF IMMUNO HISTOCHEMICAL MARKERS IN CARCINOMA BREAST-OUR EXPERIENCE IN A TERTIARY CARE HOSPITAL

  2021cites this paper
• A PROSPECTIVE STUDY ON RELATION OF HISTOLOGICAL GRADE AS WELLAS HORMONE RECEPTOR PROFILE IN LOCALLY ADVANCED BREAST CARCINOMA PATIENTS IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY

  2021cites this paper
• Comparison of ER, PR and HER-2/NEU reactivity pattern with histological grade, type, tumour size, Lymphovascular invasion, mitotic index and lymph node status in breast cancer

  2021influential citation
• Breast cancer in adolescent and young adult Ivory coast women: epidemiological and clinical features and molecular subdivision

  2021cites this paper
• Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer

  2020cites this paper
• Prevalence of Molecular Subtypes of Breast Cancer in India: a Systematic Review and Meta-analysis

  2020cites this paper
• Breast carcinoma histopathological correlation with molecular classification: A comparative study

  2020cites this paper
• Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda

  2020cites this paper
• A Study of Histomorphological Prognotic Factors and Hormone Receptor Status in Therapeutic Decision Making in a Case of Carcinoma Breast

  2019cites this paper
• Is It Time to Bid Adieu to the Traditional Histological Prognostic Parameters in Breast Carcinoma? Not Yet

  2019cites this paper
• A study of prognostic factors of breast cancer in relation to ER/PR/HER 2NEU expression

  2019cites this paper
• Clinicopathological and immunohistological profile of infiltrating ductal carcinoma breast in a tertiary care centre of western UP- A study of 100 cases

  2018cites this paper
• Study of Predictive and Prognostic Markers in Breast Cancer with Special Reference to Hormonal Receptors

  2018cites this paper
• Oncoplastic Surgery: Is It Time to Change? From Innovation to Adoption Using Mentorship Program

  2018cites this paper
• A study on the role of receptor (ER,PR,HER-2/neu) in patients of carcinoma breast

  2017cites this paper
• Improving accuracy of breast cancer biomarker testing in India

  2017cites this paper
• Correlation of Histopathological Features and Immunohistochemistry in the study of Breast Cancer

  2017cites this paper
• The Prognostic Value of Luminal Subtypes of Breast Cancer and their Impact on the Patient's Outcome

  2017cites this paper
• IMMUNOHISTOCHEMICAL PROFILE OF INFILTRATING DUCTAL CARCINOMA BREAST- PROGNOSTIC AND THERAPEUTIC USE

  2017cites this paper
• Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 status of breast cancers in women visiting the Jos University Teaching Hospital

  2017cites this paper
• Immunohistochemical Profile of Infiltrating Ductal Carcinoma Breast (Not Otherwise Specified) - A Study Of 100 Cases

  2017cites this paper
• Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer

  2017cites this paper
• Lessons from a clinicopathological study of breast cancer

  2016cites this paper
• Predictive and Prognostic Factors in Breast Cancer and their Association with ER PR HER2/neu Expression

  2016cites this paper
• Her-2/neu expression and its correlation with ER status and various clinicopathological parameters

  2016cites this paper
• Breast cancer in young: Experience at a tertiary care centre in Tirupati, Andhra Pradesh

  2016cites this paper
• Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis

  2016cites this paper
• Synovial-Like Neoplasms (Synovial Sarcoma) of the Liver

  2016cites this paper
• EXPRESSION OF CK5 BASAL CYTOKERATIN DURING METASTATIC DEVELOPMENT OF BREAST CARCINOMA

  2016cites this paper
• Clinico-morphological profile and receptor status in breast cancer patients in a South Indian institution.

  2014cites this paper
• Distinct breast cancer subtypes in women with early-onset disease across races.

  2014cites this paper
• Breast carcinoma in young females below the age of 40 years: A histopathological perspective

  2014cites this paper